Randomized placebo-and active controlled study of eplivanserin, a novel sleep agent, on next-day psychomotor and cognitive tasks in healthy subjects

被引：0
|
作者：
Micallef-Roll, J.
Roy, C.
Delfolie, A.
Pinquier, J. L.
Blin, O.
机构：
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2009年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
544
引用
收藏
页码：108 / 108
页数：1
相关论文
共 50 条
  • [31] A randomized, double blind, placebo and active comparator controlled pilot study of UP446, a novel dual pathway inhibitor anti-inflammatory agent of botanical origin
    John S Sampalis
    Lidia Alfaro Brownell
    Nutrition Journal, 11
  • [32] First Clinical Experience with ONO-4232: A Randomized, Double-blind, Placebo-controlled Healthy Volunteer Study of a Novel Lusitropic Agent for Acutely Decompensated Heart Failure
    Ward, Caroline L.
    Jamieson, Virginia
    Nabata, Toshiya
    Sharpe, John
    Dozono, Koji
    Suto, Fumitaka
    Hashimoto, Yoshitaka
    Gussak, Ihor
    CLINICAL THERAPEUTICS, 2016, 38 (05) : 1109 - 1121
  • [33] Clinical evaluation of a novel gallotannin-enriched Galla Rhois extract (GRE) on vital cognitive functions in healthy volunteers: A randomized, double-blind, placebo-controlled study
    Heuer, Marvin
    Baker, Christopher
    Sedlak, Michael
    Woo, Kim Jin
    Kee, Kim Hyun
    Bagchi, Debasis
    FUNCTIONAL FOODS IN HEALTH AND DISEASE, 2023, 13 (10): : 487 - 504
  • [34] A RANDOMIZED, PLACEBO CONTROLLED, SINGLE ASCENDING DOSE STUDY TO ASSESS THE SAFETY, PK, AND PD OF DS-9001A, A NOVEL SMALL BIOLOGIC PCSK9 INHIBITORS, IN HEALTHY SUBJECTS.
    Kato, M.
    He, L.
    McGuire, K.
    Dishy, V.
    Zamora, C. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S72 - S72
  • [35] Cannabinol (CBN; 30 and 300 mg) effects on sleep and next-day function in insomnia disorder (′CUPID′ study): protocol for a randomised, double-blind, placebo-controlled, cross-over, three-arm, proof-of- concept trial
    Lavender, Isobel
    McCartney, Danielle
    Marshall, Nathaniel
    Suraev, Anastasia
    Irwin, Chris
    DRozario, Angela L.
    Gordon, Christopher J.
    Saini, Bandana
    Grunstein, Ronald R.
    Yee, Brendon
    McGregor, Iain
    Hoyos, Camilla M.
    BMJ OPEN, 2023, 13 (08):
  • [36] A Randomized, Double-Blind, Placebo- and Active-Controlled, Escalating Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Profiles of Subcutaneous Eflapegrastim in Healthy Japanese and Caucasian Subjects
    Jeon, Yoomin
    Lee, Nora
    Baek, Seungjae
    Choi, JaeDuk
    Jhee, Stanford
    Lee, Howard
    DRUGS IN R&D, 2022, 22 (01) : 71 - 87
  • [37] A Randomized, Double-Blind, Placebo- and Active-Controlled, Escalating Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Profiles of Subcutaneous Eflapegrastim in Healthy Japanese and Caucasian Subjects
    Yoomin Jeon
    Nora Lee
    Seungjae Baek
    JaeDuk Choi
    Stanford Jhee
    Howard Lee
    Drugs in R&D, 2022, 22 : 71 - 87
  • [38] A randomized double-blind placebo-controlled 4-way crossover study investigating the residual psychomotor and cognitive effects of single oral doses of a new zolpidem modified-release formulation in healthy elderly volunteers.
    Hindmarch, I
    Legangeux, E
    Zobouyan, I
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P66 - P66
  • [39] Pharmacokinetics and Tolerability of LC28-0126, a Novel Necrosis Inhibitor, After Multiple Ascending Doses: A Phase I Randomized, Double-blind, Placebo-controlled Study in Healthy Male Subjects
    Kim, Eunwoo
    Hwang, Inyoung
    Lee, SeungHwan
    Oh, Jaeseong
    Chung, Hyewon
    Jin, Myungwon
    Kim, Soon Ha
    Yu, Kyung-Sang
    CLINICAL THERAPEUTICS, 2020, 42 (10) : 1946 - U11
  • [40] A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase I Study of Analgesic/Antihyperalgesic Properties of ASP8477, a Fatty Acid Amide Hydrolase Inhibitor, in Healthy Female Subjects
    Schaffler, Klaus
    Yassen, Ashraf
    Reeh, Peter
    Passier, Paul
    PAIN MEDICINE, 2018, 19 (06) : 1206 - 1218
12345